Navigation Links
EuroDYNA leaves healthy genomic research ecosystem as legacy

Europe's position as a major player in genome research has been boosted by the European Science Foundation's three-year EUROCORES programme EuroDYNA. As it draws to a close, EuroDYNA (Dynamic Nuclear Architecture and Chromatin Function) is leaving behind a healthy European ecosystem of interacting multidisciplinary research projects focused on the structure of the cellular nucleus and mechanisms governing gene expression.

The greatest benefit of EuroDYNA has been in stimulating interaction among the various Collaborative Research Projects (CRPs) that had already been established, according to Graham Tebb, a scientific administrator for genetics, microbiology, biotechnology and cell biology at the FWF (Fonds zur Frderung der Wissenschaftlichen Forschung), the Austrian agency for funding basic research. "I was pleased to see the links between the CRPs," said Tebb. "That's the real added value."

The success of EuroDYNA in creating European momentum behind research into chromatin structure and gene regulation was widely acknowledged at the programme's third and final meeting, held at the Wellcome Trust Conference Centre near Cambridge, UK, late May 2008. "The ESF grant had a galvanising effect on our project, increasing credibility on a local, national and international level," said Colin Logie from Nijmegen University in the Netherlands, head of one of the EuroDYNA projects, "Chromatin Higher Order Dynamics: A single molecule approach". Logie pointed out that research into the dynamic structure of chromatin, the nuclear complex of proteins and DNA where 99.99% of all genes reside in higher organisms, requires increasing interaction between biologists and physicists, which has been accomplished within his project, leading to new insights into chromatin structure.

Logie and other project leaders also highlighted an issue common to most if not all projects relating to genomic structure, which is the high cost of meeting the growing genome-wide profiling challenge. Rene Ketting from the Hubrecht Institute for Developmental Biology in Utrecht, in the Netherlands, and David Shore from the University of Geneva's Department of Molecular Biology, suggested there should in future be separate provision for the cost of protein chromosomal location by ChIP-seq, genome-wide RNA profiling and the concomitant bioinformatics analyses, which otherwise could easily consume budgets and reduce the resources available for dedicated laboratory experiments. Alternatively at least some aspects of genomic profiling could be provided as a service by major funding agencies or research councils. The role of EuroDYNA not just in fostering collaboration between disciplines and countries, but also in highlighting such future funding issues, was acknowledged by many of the project leaders and scientists present at the final conference.

The best measure of EuroDYNA's success though lies in the cross fertilisation between different multi-disciplinary CRPs, some of which were sparked by unexpected breakthroughs. A good example is the serendipitous discovery of the close and important relationship between two proteins, cohesin and CTCF, in regulating the expression and transcription of genes. This subsequently brought two separate groups within EuroDYNA together, one from the Institute of Molecular Pathology (IMP) in Vienna on the control of the chromosome structure by Cohesin, and the other from Erasmus Medical Centre in Rotterdamworking on the role of the zinc finger CTCF proteins in the cell cycle and differentiation processes. The discovery that cohesin and CTCF are intimately linked was made by the group of Jan-Michael Peters at the IMP. Subtle deficiencies in this relationship might lead to a group of diseases known as "cohesinopathies" that are more common than once thought because they are frequently misdiagnosed. One such disease is Cornelia de Lange syndrome, causing various developmental abnormalities such as low birth weight, delayed growth, and small head size.

EuroDYNA, and indeed the ESF in general, has made a major contribution to the development of multinational, multidisciplinary funding models that reduce the bureaucratic and logistical hurdles that scientists need to overcome both in complex and smaller scale projects, whenever European collaboration is required. However some scientists at the EuroDYNA conference argued that the ESF could stimulate collaboration even further by extending the timespan of projects from three to four or even five years, potentially with a mid-term review after three years. This was recommended by Juan Ausio from the Department of Biochemistry and Microbiology, University of Victoria. Ausio, who is a member of the EuroDYNA review panel, pointed out that in Canada funding for scientific projects typically runs for five years, and gives the scientists longer to establish lasting collaborations and derive real value from them. "It saves a lot of resources and effort," said Ausio. "It especially decreases the burden on the reviewers' side and it decreases significantly the administrative effort of the funding agencies."

Perhaps then the most lasting legacy of EuroDYNA is to leave behind a more secure structure for funding of European projects, even if some of the detail remains to be sorted out.


Contact: Dr. Angela Michiko Hama
European Science Foundation

Related medicine news :

1. Secondhand Smoke Leaves Kids Prone to Severe Infections
2. Sea Buckthorn Leaves May Hold Benefit for the Liver
3. Miracle leaves that may help protect against liver damage
4. Federal Health Plan for Children Still Leaves Needs Unmet
5. Ric Weiland Leaves $65 Million to Support Gay Rights and HIV/AIDS Organizations
6. Europes Columbus laboratory leaves Earth
7. Obesity Leaves More Americans With Physical Limitations
8. New discovery leaves blood-doping athletes scratching their heads
9. New discovery leaves blood-doping athletes scratching their heads
10. Hain Celestial to Open The NASDAQ Stock Market and Celebrate Summer With A Healthy Way of Life(TM)
11. New research shows how aging brain brings a healthy dose of perspective
Post Your Comments:
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: